Autologous hematopoietic stem cell transplantation for myelodysplastic syndromes: which cell source is preferable?
- PMID: 16769566
Autologous hematopoietic stem cell transplantation for myelodysplastic syndromes: which cell source is preferable?
Comment on
-
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).Br J Haematol. 2000 Sep;110(3):620-30. doi: 10.1046/j.1365-2141.2000.02200.x. Br J Haematol. 2000. PMID: 10997974
Publication types
MeSH terms
LinkOut - more resources
Medical